These have been reported to decrease inflammasome components levels, reduce neuroinflammation and Aβ plaques and improve cognitive impairment in AD mouse models by directly blocking NLRP3 activity [27–29,32,33,35–37,60]. The gene discussed is NLRP3; the disease is Cognitive impairment.